This work is licensed under a
Creative Commons Attribution 4.0 International License
[1] O. Prakash, D. Kumar, S. Kumar, Screening of methanol extract and ethyl acetate fraction of Abies webbiana Lindl. for neuropharmacological activities, Indian J. Pharm. Sci. 77 (2015) 536-541.
[2] B. Ghanashyam, S. Nagarathinam, India is failing the mentally ill as abuses continuing, Lancet. 376 (2010) 1633-1634.
[3] S. Sandhya, K.R. Vinod, S. Kumar, Herbs used for brain disorders, Hygeia J. Drugs Med. 2 (2010) 38-45.
[4] R.J. Baldessarini, Drugs and the treatment of psychiatric disorders, in: J.G. Hardman, L.E. Limbird (Eds. ), Goodman and Gilman's The Pharmacological Basis of Therapeutics, New York, McGraw- Hill, 2001, p.987.
[5] S. Noor et al., Evaluation of anti-inflammatory and antidiabetic activity of ethanolic extract of Desmodium pulchellum Benth (Fabaceae) barks on albino wistar rats, Journal of Applied Pharmaceutical Science. 3(7) (2013) 48-51.
[6] P. Bergner, Nervous depression and homeopathic indications of herbs, Med. Herb. 9 (1995) 12.
[7] W. Boericke, Homeopathic materia medica, Presented by Medi T, 1999, Information on: http: /www. homeoint. org/books/boericmm/b/bapt. html.
[8] J.W. Fyfe, The Essentials of modern materia medica and therapeutics, Eclectic Manual No. 6, Cincinnati, The Scudder Brothers Company, 1903, p.15.
[9] F.J. Petersen, Materia medica and clinical therapeutics, Published by F.J. California, Petersen Los Olivos, 1905, p.51.
[10] S. Tilgner, Wild Indigo: Baptisia tinctoria, Presented by Materia Medica, 1999, Information on: http: /www. herbaltransitions. com/materiamedica/Baptisia. html.
[11] A. Pengelly, K. Bennett, Appalachian plant monographs: Baptisia tinctoria (L. ) R. Vent., Wild Indigo, Maryland, Tai Sophia Institute, 2011, pp.1-15. Retrieved from http: /www. frostburg. edu/aces/appalachian-plants.
[12] N.R. Farnsworth, Biological and phytochemical screening of plants, J. Pharm. Sci. 55 (1966) 225-276.
[13] F. Sharmen et al., Investigation of in vivo neuropharmacological effects of Alpinia nigra leaf extract, Asian Pac. J. Trop. Biomed. 4 (2014) 137-142.
[14] W.C. Scheffer, Statistics for the Biological Sciences, Philippines, Addison-Wesley Publishing Company, 1980, pp.121-141.
[15] M. Komiya, T. Takeuchi, E. Harada, Lemon oil vapour causes an anti-stress effect via modulating the 5-HT and DA activities in mice, Behav. Brain Res. 172 (2006) 240-249.
[16] C. Belzung, G. Griebel, Measuring normal and pathological anxiety like behaviour in mice: A review, Behav. Brain Res. 152 (2001) 141-149.
[17] M.O. Raihan et al., Sedative and anxiolytic effects of the methanolic extract of Leea indica (Burm. f. ) Merr. Leaf, Drug Discov. Ther. 5 (2011) 185-189.
[18] E.A. Swinyard, W.C. Brown, L.S. Goodman, Comparative assays of antiepileptic drugs in mice and rats, J. Pharmacol. Exp. Ther. 3 (1952) 319-330.
[19] R. Madaan, S. Kumar, Screening of alkaloidal fraction of Conium maculatum Linn. aerial parts for analgesic and anti-inflammatory activity, Indian J. Pharm. Sci. 74 (2012) 457-460.
[20] C. Wolfman et al., Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora Coerulea, Pharmacol. Biochem. Behav. 47 (1994) 1-4.
[21] S. Kumar, A. Sharma, Apigenin: The anxiolytic constituent of Turnera aphrodisiaca, Pharm. Biol. 44 (2006) 84-90.
[22] L.T. Yi et al., Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice, Prog. Neuropsychopharmacol. Biol. Psychiatry. 34 (2010) 1223-1228.
[23] S.K. Kulkarni, A. Dhir, Berberine: A plant alkaloid with therapeutic potential for central nervous system disorders, Phytother. Res. 24 (2010) 317-324.
[24] H. Naaz et al., Anti-cholinergic alkaloids as potential therapeutic agents for Alzheimer's disease: An in silico approach, Indian J. Biochem. Biophys. 50 (2013) 120-125.
[25] Y. Qian et al., Maslinic acid, a natural triterpenoid compound from Olea europaea, protects cortical neurons against oxygen-glucose deprivation-induced injury, Eur. J. Pharmacol. 670 (2011) 148-153.
[26] R. Martin et al., Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: A potential therapeutic role, Biochem. Pharmacol. 79 (2010) 198-208.